<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://ssistrategy.com/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	>
		<channel>
		<title>The Emerging Biotech Leader</title>
		<atom:link href="https://ssistrategy.com/feed/podcast/ssi-strategy/" rel="self" type="application/rss+xml"/>
		<link>https://ssistrategy.com/podcasts/ssi-strategy/</link>
		<description>Biotech—it&#039;s complicated.

A successful product launch requires grit, determination, and clear direction.

But let’s be real, the path to launch isn’t a straight one.

There are curves, hard turns, and dead ends.

Here’s the good news, you don’t have to navigate the complexities alone.

Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.</description>
		<lastBuildDate>Tue, 07 Apr 2026 17:11:28 +0000</lastBuildDate>
		<language>en</language>
		<copyright>© 2024 SSI Strategy</copyright>
		<itunes:subtitle>Biotech—it&#039;s complicated.</itunes:subtitle>
		<itunes:author>SSI Strategy</itunes:author>
		<itunes:type>episodic</itunes:type>
		<itunes:summary>Biotech—it&#039;s complicated.

A successful product launch requires grit, determination, and clear direction.

But let’s be real, the path to launch isn’t a straight one.

There are curves, hard turns, and dead ends.

Here’s the good news, you don’t have to navigate the complexities alone.

Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.</itunes:summary>
		<itunes:owner>
			<itunes:name>SSI Strategy</itunes:name>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<itunes:image href="https://ssistrategy.com/wp-content/uploads/2024/06/mdhmni5wbmc-scaled.jpg"></itunes:image>
			<image>
				<url>https://ssistrategy.com/wp-content/uploads/2024/06/mdhmni5wbmc-scaled.jpg</url>
				<title>The Emerging Biotech Leader</title>
				<link>https://ssistrategy.com/podcasts/ssi-strategy/</link>
			</image>
		<itunes:category text="Business">
		</itunes:category>
		<itunes:category text="Science">
									<itunes:category text="Life Sciences"></itunes:category>
							</itunes:category>
		<googleplay:author><![CDATA[SSI Strategy]]></googleplay:author>
						<googleplay:description>Biotech—it&#039;s complicated.

A successful product launch requires grit, determination, and clear direction.

But let’s be real, the path to launch isn’t a straight one.

There are curves, hard turns, and dead ends.

Here’s the good news, you don’t have to navigate the complexities alone.

Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.</googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2024/06/mdhmni5wbmc-scaled.jpg"></googleplay:image>
			<podcast:locked>yes</podcast:locked>
		<podcast:guid>73c0b0af-8570-513b-a42d-1711ab123215</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.14.4" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=6.9.4</generator>

<item>
	<title>Driving Global Patient Access: Managed Access as a Strategic Lever</title>
	<link>https://ssistrategy.com/podcast/managed-access-global-patient-access-biotech/</link>
	<pubDate>Thu, 05 Feb 2026 12:45:12 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">8cca1344-57af-5c76-8d04-f4c92b555d3d</guid>
	<description><![CDATA[Nicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization. ]]></description>
	<itunes:subtitle><![CDATA[Nicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization. ]]></itunes:subtitle>
	<content:encoded><![CDATA[Nicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization. ]]></content:encoded>
	<enclosure url="https://media.transistor.fm/d340a09c/e43d1015.mp3" length="21519859" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Nicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization. ]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2026/02/ep-58-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2026/02/ep-58-podcast-featured-image.jpg</url>
		<title>Driving Global Patient Access: Managed Access as a Strategic Lever</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:22:17</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Nicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization. ]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2026/02/ep-58-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Rare Disease Commercialization: Beyond Approval</title>
	<link>https://ssistrategy.com/podcast/rare-disease-commercialization/</link>
	<pubDate>Wed, 14 Jan 2026 15:53:16 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">d1868dcb-daa3-5881-8c08-780a689a763e</guid>
	<description><![CDATA[Matt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organization.  ]]></description>
	<itunes:subtitle><![CDATA[Matt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organization.  ]]></itunes:subtitle>
	<content:encoded><![CDATA[Matt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organization.  ]]></content:encoded>
	<enclosure url="https://media.transistor.fm/8f0ed7bd/05fabb10.mp3" length="30786221" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Matt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organization.  ]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2026/01/rare-disease-commercialization.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2026/01/rare-disease-commercialization.jpg</url>
		<title>Rare Disease Commercialization: Beyond Approval</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:31:55</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Matt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organization.  ]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2026/01/rare-disease-commercialization.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Clinical Operations as a Strategic Function</title>
	<link>https://ssistrategy.com/podcast/clinical-operations-as-a-strategic-function/</link>
	<pubDate>Fri, 05 Dec 2025 08:20:42 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">f35e3fc4-53a0-5927-863f-ea494281d101</guid>
	<description><![CDATA[Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success.]]></description>
	<itunes:subtitle><![CDATA[Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success.]]></itunes:subtitle>
	<content:encoded><![CDATA[Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success.]]></content:encoded>
	<enclosure url="https://media.transistor.fm/79b2bd06/0ac19eda.mp3" length="20265713" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success.]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/12/ep-56-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/12/ep-56-podcast-featured-image.jpg</url>
		<title>Clinical Operations as a Strategic Function</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:20:59</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success.]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/12/ep-56-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>How Clinical Operations Shapes Biotech Strategy</title>
	<link>https://ssistrategy.com/podcast/how-clinical-operations-shapes-biotech-strategy/</link>
	<pubDate>Fri, 21 Nov 2025 10:19:55 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">13141d1f-77ac-5a0a-97bf-4a4cb1f5d2c5</guid>
	<description><![CDATA[Sharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational leadership determines whether innovation reaches the clinic successfully. ]]></description>
	<itunes:subtitle><![CDATA[Sharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational leadership determines whether innovation reaches the clinic successfully. ]]></itunes:subtitle>
	<content:encoded><![CDATA[Sharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational leadership determines whether innovation reaches the clinic successfully. ]]></content:encoded>
	<enclosure url="https://media.transistor.fm/6ccf40de/4cbf2435.mp3" length="44401508" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Sharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational leadership determines whether innovation reaches the clinic successfully. ]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/11/clinical-operations-in-biotech-strategy.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/11/clinical-operations-in-biotech-strategy.jpg</url>
		<title>How Clinical Operations Shapes Biotech Strategy</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:46:08</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Sharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational leadership determines whether innovation reaches the clinic successfully. ]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/11/clinical-operations-in-biotech-strategy.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>50 Episodes in: Lessons from The Emerging Biotech Leader</title>
	<link>https://ssistrategy.com/podcast/50-episodes-in-lessons-from-the-emerging-biotech-leader/</link>
	<pubDate>Mon, 10 Nov 2025 16:24:19 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">1ad0b30a-5134-5fcc-91ba-300cbef5b942</guid>
	<description><![CDATA[Podcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.]]></description>
	<itunes:subtitle><![CDATA[Podcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.]]></itunes:subtitle>
	<content:encoded><![CDATA[Podcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.]]></content:encoded>
	<enclosure url="https://media.transistor.fm/d65679d8/3b08bfad.mp3" length="35074867" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Podcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/11/50-episodes-in.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/11/50-episodes-in.jpg</url>
		<title>50 Episodes in: Lessons from The Emerging Biotech Leader</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:36:28</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Podcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/11/50-episodes-in.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Biotech Leadership: The CEO–CMO Dynamic</title>
	<link>https://ssistrategy.com/podcast/biotech-leadership-the-ceo-cmo-dynamic/</link>
	<pubDate>Fri, 07 Nov 2025 12:32:38 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">eef30170-1f8a-5f2a-b7b6-a6f57122cc4a</guid>
	<description><![CDATA[Adriana Valenciano, Senior Vice President at SSI Strategy, takes a closer look at how leadership partnerships, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. ]]></description>
	<itunes:subtitle><![CDATA[Adriana Valenciano, Senior Vice President at SSI Strategy, takes a closer look at how leadership partnerships, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. ]]></itunes:subtitle>
	<content:encoded><![CDATA[Adriana Valenciano, Senior Vice President at SSI Strategy, takes a closer look at how leadership partnerships, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. ]]></content:encoded>
	<enclosure url="https://media.transistor.fm/a70180fd/ada0aa87.mp3" length="23212451" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Adriana Valenciano, Senior Vice President at SSI Strategy, takes a closer look at how leadership partnerships, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. ]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/11/ep-54-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/11/ep-54-podcast-featured-image.jpg</url>
		<title>Biotech Leadership: The CEO–CMO Dynamic</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:24:03</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Adriana Valenciano, Senior Vice President at SSI Strategy, takes a closer look at how leadership partnerships, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. ]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/11/ep-54-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>From TPP to Teamwork: Creating Structure as a Biotech CMO</title>
	<link>https://ssistrategy.com/podcast/from-tpp-to-teamwork-creating-structure-as-a-biotech-cmo/</link>
	<pubDate>Fri, 10 Oct 2025 11:35:00 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">eef9f2b3-eb57-51ab-a54b-502573be082d</guid>
	<description><![CDATA[Dr. Ed Tucker talks about what he’s learned after serving as CMO in large pharma and startups.]]></description>
	<itunes:subtitle><![CDATA[Dr. Ed Tucker talks about what he’s learned after serving as CMO in large pharma and startups.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Ed Tucker talks about what he’s learned after serving as CMO in large pharma and startups.]]></content:encoded>
	<enclosure url="https://media.transistor.fm/dd24b5d6/65c65d54.mp3" length="37137344" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Ed Tucker talks about what he’s learned after serving as CMO in large pharma and startups.]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/10/ep-53-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/10/ep-53-podcast-featured-image.jpg</url>
		<title>From TPP to Teamwork: Creating Structure as a Biotech CMO</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:38:32</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Dr. Ed Tucker talks about what he’s learned after serving as CMO in large pharma and startups.]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/10/ep-53-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Adapting Biotech Leadership Across Development and Therapies</title>
	<link>https://ssistrategy.com/podcast/adapting-biotech-leadership-across-development-and-therapies/</link>
	<pubDate>Fri, 12 Sep 2025 09:48:53 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">https://ssistrategy.com/?post_type=podcast&#038;p=22874</guid>
	<description><![CDATA[Dr. Benit Maru, Senior Vice President at SSI Strategy, discusses how biotech leaders can guide teams through different stages of development.]]></description>
	<itunes:subtitle><![CDATA[Dr. Benit Maru, Senior Vice President at SSI Strategy, discusses how biotech leaders can guide teams through different stages of development.]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Benit Maru, Senior Vice President at SSI Strategy, discusses how biotech leaders can guide teams through different stages of development.]]></content:encoded>
	<enclosure url="https://media.transistor.fm/938a93fa/33ae1050.mp3" length="24574438" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Benit Maru, Senior Vice President at SSI Strategy, discusses how biotech leaders can guide teams through different stages of development.]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/09/ep-52-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/09/ep-52-podcast-featured-image.jpg</url>
		<title>Adapting Biotech Leadership Across Development and Therapies</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:25:29</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Dr. Benit Maru, Senior Vice President at SSI Strategy, discusses how biotech leaders can guide teams through different stages of development.]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/09/ep-52-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The CMO’s Role in Building a Scalable Biotech Strategy</title>
	<link>https://ssistrategy.com/podcast/the-cmos-role-in-building-a-scalable-biotech-strategy/</link>
	<pubDate>Fri, 29 Aug 2025 09:47:20 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">https://ssistrategy.com/?post_type=podcast&#038;p=22870</guid>
	<description><![CDATA[Dr. Michael Goldstein, ophthalmologist and multi-time Chief Medical Officer, speaks about the realities of biotech leadership across modalities and development stages. ]]></description>
	<itunes:subtitle><![CDATA[Dr. Michael Goldstein, ophthalmologist and multi-time Chief Medical Officer, speaks about the realities of biotech leadership across modalities and development stages. ]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Michael Goldstein, ophthalmologist and multi-time Chief Medical Officer, speaks about the realities of biotech leadership across modalities and development stages. ]]></content:encoded>
	<enclosure url="https://media.transistor.fm/c63b0d9d/0e9774c2.mp3" length="44720958" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Michael Goldstein, ophthalmologist and multi-time Chief Medical Officer, speaks about the realities of biotech leadership across modalities and development stages. ]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/08/ep-51-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/08/ep-51-podcast-featured-image.jpg</url>
		<title>The CMO’s Role in Building a Scalable Biotech Strategy</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:46:28</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Dr. Michael Goldstein, ophthalmologist and multi-time Chief Medical Officer, speaks about the realities of biotech leadership across modalities and development stages. ]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/08/ep-51-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Designing Patient-Centric Trials That Work</title>
	<link>https://ssistrategy.com/podcast/designing-patient-centric-trials-that-work/</link>
	<pubDate>Thu, 24 Jul 2025 14:59:15 +0000</pubDate>
	<dc:creator><![CDATA[SSI Strategy]]></dc:creator>
	<guid isPermaLink="false">https://ssistrategy.com/?post_type=podcast&#038;p=22864</guid>
	<description><![CDATA[Victoria highlights how biotech teams can start small but think deliberately when embedding patient input and cultural intent into early-stage development.]]></description>
	<itunes:subtitle><![CDATA[Victoria highlights how biotech teams can start small but think deliberately when embedding patient input and cultural intent into early-stage development.]]></itunes:subtitle>
	<content:encoded><![CDATA[Victoria highlights how biotech teams can start small but think deliberately when embedding patient input and cultural intent into early-stage development.]]></content:encoded>
	<enclosure url="https://media.transistor.fm/00fb2871/eb9176cc.mp3" length="16026317" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Victoria highlights how biotech teams can start small but think deliberately when embedding patient input and cultural intent into early-stage development.]]></itunes:summary>
	<itunes:image href="https://ssistrategy.com/wp-content/uploads/2025/07/ep-50-podcast-featured-image.jpg"></itunes:image>
	<image>
		<url>https://ssistrategy.com/wp-content/uploads/2025/07/ep-50-podcast-featured-image.jpg</url>
		<title>Designing Patient-Centric Trials That Work</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:16:35</itunes:duration>
	<itunes:author><![CDATA[SSI Strategy]]></itunes:author>	<googleplay:description><![CDATA[Victoria highlights how biotech teams can start small but think deliberately when embedding patient input and cultural intent into early-stage development.]]></googleplay:description>
	<googleplay:image href="https://ssistrategy.com/wp-content/uploads/2025/07/ep-50-podcast-featured-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
